Menorrhagia — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for menorrhagia. 22 active patents protecting 2 drugs from 2+ originators. First major cliff: 2027. Daily refresh.

2
Approved drugs
22
Active US patents
48/100
Avg vulnerability
$421M
Annual revenue covered

Originators in Menorrhagia

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Fdn Consumer 12 patents MYOVANT SCIENCES 10 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating menorrhagia. Each bar = one year. Y-axis scaled to peak year (7 patents).

2
27
7
29
4
33
1
34
1
36
6
37
1
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Jadelle
LEVONORGESTREL
 Fdn Consumer 12 48 — 2027-02-07
Orgovyx
relugolix
 MYOVANT SCIENCES 10 47 $421M 2029-01-28

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12336990 Orgovyx method of use 75 2037-09-29
12097198 Orgovyx method of use 75 2037-09-29
12144809 Orgovyx method of use 75 2037-09-29
11583526 Orgovyx method of use 70 2037-09-29
11850182 Jadelle method of use 64 2029-09-14
11850182 Jadelle method of use 64 2029-09-14
11850182 Jadelle method of use 64 2029-09-14
10786501 Orgovyx method of use 62 2037-09-29
10449191 Orgovyx method of use 62 2037-09-29
11628088 Jadelle formulation 51 2027-02-07

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
12004992 Jadelle composition of matter 0 2033-10-06
11795178 Orgovyx composition of matter 12 2033-09-27
12325714 Orgovyx composition of matter 17 2033-09-27
7300935 Orgovyx composition of matter 17 2029-01-28
11571328 Jadelle formulation 33 2040-09-07
10350170 Orgovyx formulation 42 2036-02-25
10028858 Jadelle method of use 45 2034-03-22
11090186 Jadelle method of use 45 2033-10-24
10561524 Jadelle method of use 51 2029-09-16
10561524 Jadelle method of use 51 2029-09-16

Related